Hepatobiliary disorders and complications of inflammatory bowel disease. - Wikidata - awgldk - TriplyDB

Hepatobiliary disorders and complications of inflammatory bowel disease.

Hepatobiliary disorders and complications of inflammatory bowel disease.

http://www.wikidata.org/entity/Q37905969

about

Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalk Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.De novo inflammatory bowel disease and its mimics after organ transplantation.Extraintestinal manifestations and complications in IBD.Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease.Autoimmune liver diseases and inflammatory bowel diseases in children: current issues and future perspectives.Hepatic manifestations of inflammatory bowel diseases.Colonic and Hepatic Modulation by Lipoic Acid and/or N-Acetylcysteine Supplementation in Mild Ulcerative Colitis Induced by Dextran Sodium Sulfate in Rats.

P2860

Q26829300-794B29E5-696F-47EA-9820-E12F4A549C0C Q37317444-6C47218D-EB10-48E7-A175-8FF8B15BB3CA Q38105200-33F5F50D-90B3-4181-A99F-36DFC3CA2F1A Q38120146-98738229-FD31-4DD7-8EC6-C52E28FB6379 Q38210793-47A7892F-6EFC-40C0-B7FD-D5E93BB0893A Q38747656-747564BE-8C8F-4B35-8747-451C1C3318E0 Q38814158-F1A1FDD6-2B80-41B0-B68A-38CD364E9F19 Q42277580-C93CDE0E-1B00-49BC-B610-984082D0D8FF

P2860

Hepatobiliary disorders and complications of inflammatory bowel disease.

http://www.wikidata.org/entity/Q37905969

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Hepatobiliary disorders and complications of inflammatory bowel disease.

@en

Hepatobiliary disorders and complications of inflammatory bowel disease.

@nl

type

label

Hepatobiliary disorders and complications of inflammatory bowel disease.

@en

Hepatobiliary disorders and complications of inflammatory bowel disease.

@nl

prefLabel

Hepatobiliary disorders and complications of inflammatory bowel disease.

@en

Hepatobiliary disorders and complications of inflammatory bowel disease.

@nl

P1433

Q37905969-B6832ECE-59DA-4674-A151-17AEA9046C49

P1476

Q37905969-C0B2F90C-9371-4FB8-914B-DE04DFEB6DEC

P2093

Q37905969-10A2086D-957E-40AD-A075-5361802E0763

Q37905969-44AABFE0-91E4-4017-9B0E-69BAEDD0E28A

Q37905969-4F226AED-8202-492C-9089-4088E699641F

P2860

Q37905969-0096647A-6879-449B-B388-F1A2C8D47AA6

Q37905969-030ACBA1-405A-4AEF-A909-13CD9101C452

Q37905969-03A89001-9F87-4D00-A2E3-71DFDA396F82

Q37905969-06C586A2-3271-450C-8F00-B6179656385A

Q37905969-0BB2AB71-51AB-4F9B-8C1C-54554EE4D4D4

Q37905969-0F2D8ADC-D0D8-40A3-9D67-A748A3280AA5

Q37905969-0FF4CDA3-7BE7-4A53-8C49-DB63CF654ECD

Q37905969-10C4BBDB-C614-4562-9385-D5CE26B7DF18

Q37905969-17288AD3-34A1-4572-86CC-3A763E2AA3CB

Q37905969-180436D2-05C2-4ACF-AEAD-BB1B5684E1FF

P304

Q37905969-DD0F3BC0-CD22-4556-8F49-DC92B7196F55

P31

Q37905969-EF00392E-6083-46FA-9D6C-7900E41D6E9D

P356

Q37905969-D892E947-61BB-4FE8-ACAB-3BA6346B74EF

P433

Q37905969-2C10AD82-3058-4C7C-93E7-90DE85BBCE3C

P478

Q37905969-42316A5B-F4F4-44CF-B257-52CEECD88320

P577

Q37905969-0B45B37C-DC1B-4BE8-9D08-DB009F195ACE

P5875

Q37905969-1C128F20-2DD1-459F-A1E6-946EBD7D323A

P698

Q37905969-034CF5DE-A0CF-48E5-96CA-34F53C64E388

P921

Q37905969-73C698BD-BE48-41A3-86A9-8CDD2D26CF0B

P356

J.1751-2980.2011.00511.X

P1433

Journal of Digestive Diseases

P1476

Hepatobiliary disorders and complications of inflammatory bowel disease.

@en

P2093

Bo Shen

http://www.w3.org/2001/XMLSchema#string

Preethi Gk Venkatesh

http://www.w3.org/2001/XMLSchema#string

Udayakumar Navaneethan

http://www.w3.org/2001/XMLSchema#string

P2860

Primary Sclerosing Cholangitis, Inflammatory Bowel Disease, and Colon Cancer

Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis

Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.

Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.

Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis

Autoimmune overlap syndromes.

Septic thrombophlebitis of the portal vein (pylephlebitis): diagnosis and management in the modern era.

P304

245-256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1751-2980.2011.00511.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51522834

http://www.w3.org/2001/XMLSchema#string

P698

21791019

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases